OSI Pharma (OSIP) Receives Notification of ANDA Filing for Tarceva; Canaccord Analyst Says Patent Threat Remains an Overhang
Tweet Send to a Friend
This morning, OSI Pharmaceuticals (Nasdaq: OSIP) announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals USA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
